Cargando…
Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies
Pancreatic cancer will be positioned by the year 2030 as the second cause of oncological death after lung cancer. The pathophysiology of the most common variety, which involves the adenocarcinoma of the pancreas, represents one of the main challenges for current oncology to explain its tumorigenesis...
Autores principales: | Ortega, Miguel A., Pekarek, Leonel, Fraile-Martinez, Oscar, Garcia-Montero, Cielo, Saez, Miguel A., Asúnsolo, Angel, Alvarez-Mon, Miguel A., Monserrat, Jorge, Ruiz-Llorente, Lidia, García-Honduvilla, Natalio, Albillos, Agustin, Buján, Julia, Alvarez-Mon, Melchor, Guijarro, Luis G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027548/ https://www.ncbi.nlm.nih.gov/pubmed/35448172 http://dx.doi.org/10.3390/curroncol29040198 |
Ejemplares similares
-
Towards an updated view on the clinical management of pancreatic adenocarcinoma: Current and future perspectives
por: Pekarek, Leonel, et al.
Publicado: (2021) -
Oxidative Stress Markers Are Associated with a Poor Prognosis in Patients with Pancreatic Cancer
por: Ortega, Miguel A., et al.
Publicado: (2022) -
Understanding Chronic Venous Disease: A Critical Overview of Its Pathophysiology and Medical Management
por: Ortega, Miguel A., et al.
Publicado: (2021) -
Tissue remodelling and increased DNA damage in patients with incompetent valves in chronic venous insufficiency
por: Ortega, Miguel A., et al.
Publicado: (2021) -
Overexpression of glycolysis markers in placental tissue of pregnant women with chronic venous disease: a histological study
por: Ortega, Miguel A, et al.
Publicado: (2022)